Altamira Therapeutics Ltd.: xbrl:AdjustmentsForFinanceCosts

Value{"unit": "CHF", "value": 520125}
Period2018-01-01 – 2018-12-31
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001601936-19-000008
Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/26f233d9-c9e8-430c-be9f-db78b13557f5

History